Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
about
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selectionDown-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cellsBringing estrogen receptors under control.Cancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesMolecular determinants of context-dependent progesterone receptor action in breast cancerTherapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.Functional implications of altered subcellular localization of PELP1 in breast cancer cells.Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complexProgesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexesIntegrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancerBCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.Pathways to tamoxifen resistance.Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferationAltering the estrogenic milieu of breast cancer with a focus on the new aromatase inhibitors.Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model.Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivityLong-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model.Tracking progesterone receptor-mediated actions in breast cancerYM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells.Progesterone action in breast, uterine, and ovarian cancers.Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells.Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expressionHypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancerOestrogen receptor: a stable phenotype in breast cancerPharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinaseIrreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivationJostling for position: optimizing linker location in the design of estrogen receptor-targeting PROTACs.Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.Mechanisms of endocrine resistance in breast cancer.Tamoxifen resistance in breast cancer.Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer.Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.
P2860
Q24605762-B8AEEE4C-E699-41FC-872C-BB9F73353F39Q24672087-11B2F558-DBFC-493C-91B7-6ABF72EEBC84Q24800471-44A19459-296B-45FA-B596-FB72B216C706Q26743510-E0A8ECCA-4777-4929-A24A-1A403EC15BBAQ26997928-405BCA97-8DA9-48D2-9D9B-7491D6B27D9CQ27851564-38A277B5-C144-4258-91D4-CBADDAC12044Q28270490-D15CC9E5-658B-44B1-B0DE-1D0E9127C5A9Q28301066-CFFF2219-B857-46A2-9559-E3F27D22CF90Q28306753-1B9EE8D4-FDE5-4DFD-8F68-5875E1F1B153Q28816965-CB231E65-424B-47B4-83CF-49D73D6130AEQ30432099-6AF7A872-BCBB-407F-B837-7026A3DD613CQ30441001-32873B47-543E-4889-ADF2-DD3EEC3B7E21Q30441321-2DE1B931-0B22-4E7E-8DBC-C33561B97562Q31120324-765C0EA4-FBAA-4910-86CB-527953418E6DQ33612070-0B4667FA-B669-46E1-9CCB-A00E018D213AQ33871478-C44387E4-D2A0-4EE0-99FD-C4E0CB9614A1Q34016364-7D6EF14E-0C44-4C3E-939F-924374A8C3CDQ34070890-9F6B3802-99CB-4437-9CCC-67F497F7A145Q34084662-8119D8A9-AD89-495A-ACC6-FD7F72870256Q34388848-3190E455-CFF5-450F-B2F5-0DB352C07471Q34795766-5D79A88A-CBF0-4653-922E-D422DA5C8999Q35108906-2815C7E7-6CB6-4AF0-8ECA-51A38E716033Q35113788-71633052-178C-46BD-9DB9-0167DC5C5FFCQ35191588-F0C11AA8-A1BE-487B-8D64-A4F125961EB3Q35225077-1AD40B87-D4EB-4567-99E0-4E01A5E95B71Q35230023-26FCC4F3-E8D6-46F7-B0E9-0E8C1A6D529FQ35786706-8382967A-9C0A-462E-BB2A-CAF55664B9E5Q35786712-9A90D5AC-6C8B-40D0-8AA8-C05AB501CB11Q36095385-5D90F4B8-5E4B-47FB-929F-B51AFE43E4CEQ36134377-87B4939C-849B-46A7-8CF6-1AC549DDF2F5Q36135818-118E3008-FA27-4340-A3CF-7388CF82B6D9Q36138978-5B932364-B4D4-4772-9197-1C3FD8E801A6Q36452355-D7BCA6BD-38CE-4729-9CC5-31AE07221BC0Q36619003-40CAF10E-D61A-48AC-B7C9-741E1DB6A97EQ36621886-249B3DF2-6B95-4CC8-9809-5944FDFD152BQ36851417-52928A94-857E-42B4-9A3E-745618F17284Q37224555-24E930FE-0402-4151-8230-7D471BEF05C8Q37254804-BA2E779D-45F9-4DE0-AA14-6887002DD456Q37346786-35A1AB97-42E9-4216-B49E-1950445C6160Q37913359-52059386-FD2B-43D0-940D-F8186D0F27C9
P2860
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@ast
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@en
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@nl
type
label
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@ast
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@en
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@nl
prefLabel
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@ast
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@en
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@nl
P2093
P356
P1476
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
@en
P2093
Encarnación CA
McGuire WL
Osborne CK
P2888
P304
P356
10.1007/BF00665801
P407
P577
1993-01-01T00:00:00Z
P6179
1030257873